Sylvain Lehmann

20.5k citations
319 papers · 12.3k · 3 hit papers · h-index 58

Impact in

Papers in

    • Prion Diseases and Protein Misfolding 97
    • RNA regulation and disease 15
    • Metabolomics and Mass Spectrometry Studies 14
    • Alzheimer's disease research and treatments 48

Sylvain Lehmann

311 papers receiving 12.1k citations

Sylvain Lehmann's Hit Papers

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease 2019 · 361 citations
3610+10+20Years since publication200400600

Peers

Sylvain Lehmann
Comparison fields: 5 of 163
  • Neurology 2.8k
  • Nutrition and Dietetics 2.2k
  • Molecular Biology 7.6k
  • Physiology 2.5k
  • Neurology 941
Replace Markus Glatzel with:
Markus Glatzel Germany
Catriona McLean Australia
Armin Giese Germany
Edward J. Goetzl United States
Nigel M. Hooper United Kingdom
Tetsuya Terasaki Japan
Toru Iwaki Japan
Gábor G. Kovács Austria
Frank Baas Netherlands
Zhen Zhao United States
Sylvain Lehmann relative to Markus Glatzel Germany Markus Glatzel's profile →
Citations per field
00.5×1.5×1.9×
Markus Glatzel · 1×
Citations per year

Countries citing papers authored by Sylvain Lehmann

Since Specialization
Citations

This map shows the geographic impact of Sylvain Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Lehmann more than expected).

Fields of papers citing papers by Sylvain Lehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Lehmann. The network helps show where Sylvain Lehmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Sylvain Lehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sylvain Lehmann Line = papers co-authored together Sylvain Lehmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 319 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Signal Transduction Through Prion Protein
Hit paper breakdown →
2000634
2
Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured Cells
Hit paper breakdown →
1995606
3 2011408
4
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
Hit paper breakdown →
2019361
5 2004264
6 2008254
7 2012254
8 2011234
9 2000204
10 2000177
11 2001176
12 2020161
13 2003157
14 2004156
15 2003156
16 2004150
17 2015146
18 1997146
19 1995141
20 2010134

About Sylvain Lehmann

Sylvain Lehmann is a scholar working on Molecular Biology, Physiology, Neurology, Nutrition and Dietetics and Neurology, having authored 319 papers that have together received 12.3k indexed citations. Recurring topics across this work include Prion Diseases and Protein Misfolding (97 papers), Alzheimer's disease research and treatments (48 papers), Neurological diseases and metabolism (43 papers), Trace Elements in Health (38 papers), Dementia and Cognitive Impairment Research (26 papers), Advanced Proteomics Techniques and Applications (24 papers), RNA regulation and disease (15 papers) and Metabolomics and Mass Spectrometry Studies (14 papers). The work is most often cited by research in Neurology (2.8k citations), Nutrition and Dietetics (2.2k citations), Molecular Biology (7.6k citations), Physiology (2.5k citations) and Neurology (941 citations). Sylvain Lehmann has collaborated with scholars based in France, United States and Spain. Frequent co-authors include David A. Harris, Christophe Hirtz, Audrey Gabelle, Alain Mangé, Jacques Grassi, Krista L. Moulder, Show‐Ling Shyng, Ollivier Milhavet, Jérôme Vialaret and Carole Crozet. Their work appears in journals such as Journal of Biological Chemistry, Alzheimer s & Dementia, Journal of Alzheimer s Disease, Clinical Chemistry and Laboratory Medicine (CCLM) and Alzheimer s Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact